Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg / day) in a B.I.D. regimen

Michael W. Jones, Warren T. Blume, A. Guberman, M.A Lee, Neelan Pillay, Donald F. Weaver, Felix Veloso, T A H Holdich

Seizure · 2002 · 21 citations · 7 references

DOIFull text

Open access

Concepts

References

7